Capricor Therapeutics
CAPR
CAPR
107 hedge funds and large institutions have $136M invested in Capricor Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 38 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
22% less capital invested
Capital invested by funds: $174M → $136M (-$37.5M)
41% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 29
Holders
107
Holding in Top 10
–
Calls
$61.2M
Puts
$69.8M
Top Buyers
| 1 | +$1.77M | |
| 2 | +$1.68M | |
| 3 | +$1.55M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$796K |
| 5 |
HSA
HBK Sorce Advisory
Erie,
Pennsylvania
|
+$772K |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$4.84M | |
| 3 | -$3.95M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.73M |
| 5 |
Goldman Sachs
New York
|
-$3.37M |
